Armen Shanafelt is Director at Aeglea BioTherapeutics, Inc. (AGLE). They have made 4 open-market trades across 4 companies since 2016, most recently 2021-12-13.
CIK 0001656151
4 open-market purchases totalling $15.8M since 2016, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.